CELLDEX THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$30.10
+0.70%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-6.5%
3 months
-20.1%
6 months
-6.8%
1 year
+15.8%
Year to date
+10.8%
52-week range
$22.58 – $44.87
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$2.36B
P/E
-7.9
P/B
3.3
P/S
14,960.1
Revenue
$158K
Net income
-$300.55M
Diluted EPS
-4.36
Gross margin
100.00%
Net margin
-190220.90%
Return on equity
-52.40%
Total debt
$4.9M
Cash
$47.45M
Free cash flow
-$242.11M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $22K | -$73.5M | 100.00% | -334104.50% | -$60.59M |
| Mar 31, 2026 | $15K | -$78.69M | 100.00% | -524566.70% | -$67.23M |
| Dec 31, 2025 | $121K | -$81.32M | 100.00% | -67204.10% | -$65.22M |
| Sep 30, 2025 | $0 | -$67.04M | — | — | -$49.07M |
| Jun 30, 2025 | $730K | -$56.6M | 100.00% | -7753.40% | -$44.73M |
| Mar 31, 2025 | $695K | -$53.8M | 100.00% | -7740.40% | -$54.64M |
| Dec 31, 2024 | $1.18M | -$47.09M | 100.00% | -4007.80% | -$33.23M |
| Sep 30, 2024 | $3.19M | -$42.12M | 100.00% | -1320.00% | -$55.88M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CLDX news
All market newsNo ticker-linked stories are in the current archive.